AI Solutions for Biotech

From CvilleBioHub: Convergence of AI for applications in biotech is well beyond science fiction. Currently, over 90% of molecules discovered using traditional techniques fail in human clinical trials. Inefficiencies plague the process from discovery throughout the drug development process. Advances in machine learning techniques present a major opportunity for the biopharma industry.

Join us for a discussion with a panel of local leaders in industry and data science. We aim to explore the promise of artificial intelligence and machine learning approaches in drug discovery and development.

Moderator:

• Catherine Williams, Amgen

Panelists:

• Mark Lawson, HemoShear Therapeutics
• Amrie Grammer, AMPEL BioSolutions
• Kimberly Kelly, ZielBio
• Francesca Moraca, Schrodinger

More information & registration